Results 241 to 250 of about 367,967 (298)

Advances in Complement Inhibitory Strategies for the Treatment of Glomerular Disease: A Rapidly Evolving Field. [PDF]

J Clin Med
Conversano E, Vivarelli M.
europepmc   +1 more source

Exploring Electronic States and Ultrafast Electron Dynamics in AlInP Window Layers: The Role of Surface Reconstruction

Advanced Functional Materials, EarlyView.
This study examines the surface characteristics of AlInP (001), crucial for advanced solar cells and photoelectrochemical devices. Using theoretical modeling and experiments, it identifies how phosphorus‐rich and indium‐rich surfaces create mid‐gap states that pin the Fermi level and influence ultrafast electron dynamics.
Mohammad Amin Zare Pour, Sahar Shekarabi, Isaac Azahel Ruiz Alvarado, Jonathan Diederich, Yuyings Gao, Agnieszka Paszuk, Dominik C. Moritz, Wolfram Jaegermann, Dennis Friedrich, Roel van de Krol, Wolf Gero Schmidt, Thomas Hannappel   +11 more
wiley   +1 more source

Chronic kidney disease enhances alternative pathway activity: a new paradigm. [PDF]

J Clin Invest
Jalal DI, Thurman JM, Smith RJ.
europepmc   +1 more source

Proteins of the SubB family provide multiple mechanisms of serum resistance in <i>Yersinia pestis</i>. [PDF]

Emerg Microbes Infect
Pierre F, Baillez A, Dewitte A, Rolandelli A, Sebbane F.   +4 more
europepmc   +1 more source

Serum Complement Factor H: A Marker for Progression and Outcome Prediction Towards Immunotherapy in Cutaneous Squamous Cell Carcinoma. [PDF]

Cancers (Basel)
Geidel G, Adam L, Bänsch S, Fekade N, Deitert B, Rünger A, Kött J, Zell T, Heidrich I, Smit DJ, Pantel K, Schneider SW, Gebhardt C.   +12 more
europepmc   +1 more source

Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse events. [PDF]

J Neurol
Müller-Jensen L, Möhn N, Skripuletz T, Carl S, Thomas J, Grote-Levi L, Nay S, Ivanyi P, von Wasielewski I, Gutzmer R, Dittmayer C, Stenzel W, Knauss S, Endres M, Lünemann JD, Boehmerle W, Huehnchen P.   +16 more
europepmc   +1 more source

Current Understanding of the Pathogenesis of ANCA-Associated Vasculitis and Novel Treatment Options Targeting Complement Activation. [PDF]

Life (Basel)
Drouzas K, Kalogeropoulos P, Liapis G, Lionaki S.   +3 more
europepmc   +1 more source

The same human complement factor B allele of major histocompatibility complex (MHC) class III allele is conserved in chimpanzee and gorilla, stressing its immune importance

Antonio Arnaiz‐Villena, Christian Vaquero‐Yuste, Ignacio Juárez, José Manuel Martín‐Villa, Fabio Suárez‐Trujillo   +4 more
openalex   +1 more source

CTx001 for geographic atrophy: a gene therapy expressing soluble, truncated complement receptor 1 (mini-CR1)

Rathi S, Didangelos A, Pisarenka S, Green R, Emery-Billcliff P, Patel N, Whalley P, Zamira P, Tilakaratna V, Szula E, Hasan R, Munye M, Unwin RD, Bishop PN, Keefe D, Clark SJ.   +15 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Detection of Complement Factor B Autoantibodies by ELISA

2021
Antibodies to autoantigens are implicated in a large number of diseases. Such autoantibodies may cause pathological activation of complement, an ancient humoral recognition and effector system of innate immunity; in addition, complement components or regulators may be target of autoantibodies and cause abnormal complement activation or function ...
Barbara Uzonyi, Mihály Józsi
openaire   +2 more sources